MAK CAPITAL ONE LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 94 filers reported holding RECRO PHARMA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MAK CAPITAL ONE LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q2 2021$2,112,000
-38.2%
914,235
-25.3%
0.42%
-48.2%
Q1 2021$3,416,000
+41.0%
1,224,264
+44.0%
0.81%
+25.0%
Q4 2020$2,423,000
+62.3%
850,129
+19.6%
0.65%
+3.5%
Q3 2020$1,493,000
-67.3%
711,043
-29.2%
0.63%
-73.1%
Q2 2020$4,570,000
+44.0%
1,004,466
+158.6%
2.33%
-16.7%
Q1 2020$3,173,000388,4172.80%
Other shareholders
RECRO PHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
Athyrium Capital Management, LP 2,202,420$6,145,0003.11%
Samjo Capital LLC 560,000$1,562,0001.16%
MAK CAPITAL ONE LLC 1,224,264$3,416,0000.81%
Cowen Prime Services LLC 470,500$1,313,0000.50%
Portolan Capital Management 1,957,283$5,461,0000.43%
Parkman Healthcare Partners LLC 601,967$1,679,0000.39%
Rubric Capital Management LP 1,076,587$3,004,0000.18%
Frontier Wealth Management LLC 49,112$2,142,0000.16%
ESSEX INVESTMENT MANAGEMENT CO LLC 466,992$1,303,0000.16%
AWM Investment Company, Inc. 391,304$1,092,0000.12%
View complete list of RECRO PHARMA INC shareholders